Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Rimm

Showing results (61-70 of 412) with videos related to

Pageof 42
Sort By:
The American Journal of Pathology|March 16, 2010
In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosisVeronique Neumeister, Seema Agarwal, Jennifer Bordeaux, et al.
Cancer Research|April 3, 2003
Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcomeRobert L Camp, Marisa Dolled-Filhart, Bonnie L King, et al.
Cancer Journal (Sudbury, Mass.)|September 12, 2003
Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosisWen Xie, David L Rimm, Yong Lin, et al.
Cancer|March 31, 2009
Quantitative multiplexed analysis of ErbB family coexpression for primary breast cancer prognosis in a large retrospective cohortJennifer M Giltnane, Christopher B Moeder, Robert L Camp, et al.
The American Journal of Pathology|August 11, 2012
Measurement of aldehyde dehydrogenase 1 expression defines a group with better prognosis in patients with non-small cell lung cancerAnastasios Dimou, Veronique Neumeister, Seema Agarwal, et al.
NPJ Breast Cancer|September 14, 2018
Correlating nuclear morphometric patterns with estrogen receptor status in breast cancer pathologic specimensRishi R Rawat, Daniel Ruderman, Paul Macklin, et al.
Acta Cytologica|October 9, 2002
p53 mutations as tumor markers in fine needle aspirates of palpable breast massesDeborah A Dillon, Emanuel Hipolito, Karl Zheng, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 16, 2014
Quantitative measurement of cancer tissue biomarkers in the lab and in the clinicDaniel E Carvajal-Hausdorf, Kurt A Schalper, Veronique M Neumeister, et al.
Oral Oncology|November 10, 2018
Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinomaDouglas J Hartman, Fahad Ahmad, Robert L Ferris, et al.
BMC Cell Biology|August 23, 2007
Utility of multispectral imaging for nuclear classification of routine clinical histopathology imageryLaura E Boucheron, Zhiqiang Bi, Neal R Harvey, et al.
Pageof 42

Showing results (61-70 of 412) with videos related to

Sort By:
Pageof 42
The American Journal of Pathology|March 16, 2010
In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosisVeronique Neumeister, Seema Agarwal, Jennifer Bordeaux, et al.
Cancer Research|April 3, 2003
Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcomeRobert L Camp, Marisa Dolled-Filhart, Bonnie L King, et al.
Cancer Journal (Sudbury, Mass.)|September 12, 2003
Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosisWen Xie, David L Rimm, Yong Lin, et al.
Cancer|March 31, 2009
Quantitative multiplexed analysis of ErbB family coexpression for primary breast cancer prognosis in a large retrospective cohortJennifer M Giltnane, Christopher B Moeder, Robert L Camp, et al.
The American Journal of Pathology|August 11, 2012
Measurement of aldehyde dehydrogenase 1 expression defines a group with better prognosis in patients with non-small cell lung cancerAnastasios Dimou, Veronique Neumeister, Seema Agarwal, et al.
NPJ Breast Cancer|September 14, 2018
Correlating nuclear morphometric patterns with estrogen receptor status in breast cancer pathologic specimensRishi R Rawat, Daniel Ruderman, Paul Macklin, et al.
Acta Cytologica|October 9, 2002
p53 mutations as tumor markers in fine needle aspirates of palpable breast massesDeborah A Dillon, Emanuel Hipolito, Karl Zheng, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 16, 2014
Quantitative measurement of cancer tissue biomarkers in the lab and in the clinicDaniel E Carvajal-Hausdorf, Kurt A Schalper, Veronique M Neumeister, et al.
Oral Oncology|November 10, 2018
Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinomaDouglas J Hartman, Fahad Ahmad, Robert L Ferris, et al.
BMC Cell Biology|August 23, 2007
Utility of multispectral imaging for nuclear classification of routine clinical histopathology imageryLaura E Boucheron, Zhiqiang Bi, Neal R Harvey, et al.
Pageof 42